Using a smartwatch to monitor blood pressure and glucose levels.
Laser Spatiotemporal Photoplethysmogram and Computational Method for Extended Chronic Cardiometabolic Therapeutic Care
This study is testing whether a smartwatch can accurately monitor blood pressure and glucose levels to see if it can replace traditional methods for people with chronic health issues.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 200 (estimated) |
| Ages | 21 Years and up |
| Sex | All |
| Sponsor | National Heart Centre Singapore Academic / other |
| Locations | 1 site (Singapore) |
| Trial ID | NCT06717646 on ClinicalTrials.gov |
What this trial studies
This observational study aims to evaluate the effectiveness of a smartwatch monitor that functions as a blood pressure measurement device, potentially replacing traditional cuff-based methods. Participants, both inpatients and outpatients, will wear the LSPPG wearable sensor daily to capture blood pressure and ECG readings. The study will assess the feasibility and accuracy of this innovative approach in managing chronic disorders related to blood glucose and blood pressure. Measurements will be taken at specified intervals to gather comprehensive data on the device's performance.
Who should consider this trial
Good fit: Ideal candidates for this study are adults over 21 years old who can communicate in English, Chinese, Malay, or Tamil and can provide informed consent.
Not a fit: Patients with skin sensitivity to adhesives may not benefit from this study due to potential discomfort or adverse reactions.
Why it matters
Potential benefit: If successful, this study could lead to a more convenient and accurate method for monitoring blood pressure and glucose levels in patients.
How similar studies have performed: While the approach of using wearable technology for monitoring health metrics is gaining traction, this specific application of the LSPPG sensor is relatively novel and has not been extensively tested in prior studies.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Above 21 years of age * Sufficient language skills in English, Chinese, Malay or Tamil * Provided informed consent Exclusion Criteria: * Skin sensitivity to adhesives
Where this trial is running
Singapore
- National Heart Centre Singapore — Singapore, Singapore (Recruiting)
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.